| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |